Clinical Trials in Chicago

Showing 19021-19040 of 20,493 trials

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

NCT00865228

The purpose of this study is to determine the role of time of dosing on the lipid-lowering effects of lapaquistat acetate, once daily (QD) or twice daily (BID), in subjects with hypercholesterolemia.

Hypercholesterolemia

Takeda224 participantsStarted Jul 2007

Long Beach, California, United States • Sacramento, California, United States • San Diego, California, United States +19 more locations

COMPLETEDPhase 32.2 miles

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520

The purpose of this study is to compare the effectiveness, safety, and tolerability of 3 anti-HIV combination treatments that do not use protease inhibitors (PIs). The current rule for starting treatment of HIV infection is to combine members from different classes of anti-HIV drugs, such as 2 nucleoside reverse transcriptase inhibitors (NRTIs) and either a PI or a nonnucleoside reverse transcriptase inhibitor (NNRTI). However, these combinations can be complicated and difficult to take, can cause a number of side effects, and may become ineffective. Combinations that are simpler, better tolerated, and more effective are needed. Because PIs can cause long-term side effects and because HIV can become resistant to many of them at the same time, anti-HIV combination treatments that do not use PIs are being tested.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)1,125 participants

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +57 more locations

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Find Trials by Condition in Chicago

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Safety Study of AMI MultiStem® to Treat Heart Attacks

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Dose Finding Posterolateral Thoracotomy Study